6 - Magnolia A - Oncology

2:45 PMBrian Crossley, Beth Israel Deaconess Medical CenterTestosterone Breakthrough Risk with Eligard® vs Lupron® During Drug Shortage
3:00 PMKatelin Ivey, Geisinger Medical CenterIncidence of Febrile Neutropenia in Cyclin-Dependent Kinase Inhibitors
3:15 PMKrishna Patel, Robert Wood Johnson University HospitalImpact of Pre- and Post-Subcutaneous Daratumumab Implementation on the Rate of Hypersensitivity Reactions
3:30 PMSydney Tu, Massachusetts General HospitalInpatient Use of Leuprolide in Oncology Patients
3:45 PMKathryn Rechenberg, Massachusetts General HospitalTherapeutic Enoxaparin Dosing in Thrombocytopenic Leukemia Patients 
4:00 PMKyle Lamb, Hospital of the University of PennsylvaniaCharacterization of Outcomes of Delayed Immunotherapy Initiation in Extensive Stage Small Cell Lung Cancer Patients
4:15 PMAlyssa Cendagorta, University of Rochester Medical CenterEvaluation of clotting and bleeding risk associated with the use of asparaginase products in patients with acute lymphoblastic leukemia
4:30 PMSlavka Simic, Englewood Hospital and Medical CenterEvaluation of Biosimilar Utilization Following Implementation of Oncology Computerized Physician Order Entry (CPOE) at a Community Hospital

Brian Crossley

Katelin Ivey

Krishna Patel

Sydney Tu

Kathryn Rechenberg

Kyle Lamb

Alyssa Cendagorta

Slavka Simic

Mark Attilio (Moderator)

Tamara Kitsul (Moderator)

Key:

Complete
Failed
Available
Locked